Chemopulp Tissues Stock Price Analysis and Quick Research Report. Is Chemopulp Tissues an attractive stock to invest in?
Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.
Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements.
Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Chemopulp Tissues.
-
PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Chemopulp Tissues has a PE ratio of 0 which is low and comparatively undervalued.
-
Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Chemopulp Tissues has ROA of -3.15239108010179% which is a bad sign for future performance. (Higher values are always desirable.)
-
Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Chemopulp Tissues has a Current ratio of 2.13593669443758.
-
Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Chemopulp Tissues has a ROE of -6.54616421862709%. (Higher is better)
-
Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Chemopulp Tissues has a Debt to Equity ratio of 0.322574805696986 which means that the company has low proportion of debt in its capital.
-
Sales growth: Chemopulp Tissues has reported revenue growth of -12.968502061335% which is poor in relation to its growth and performance.
-
Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Chemopulp Tissues for the current financial year is 0.245383455634241%.
-
Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Chemopulp Tissues is Rs 0 and the yield is 0%.
-
Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Chemopulp Tissues is Rs -1.0176. The higher the EPS, the better it is for investors.
One can find all the Financial Ratios of Chemopulp Tissues in Ticker for free. Also, one can get the intrinsic value of Chemopulp Tissues by using Valuation Calculators, which are available with a Finology ONE subscription.
Chemopulp Tissues FAQs
Q1. What is Chemopulp Tissues share price today?
Ans: The current share price of Chemopulp Tissues is Rs 0.
Q2. What is the market capitalisation of Chemopulp Tissues?
Ans: Chemopulp Tissues has a market capitalisation of Rs 0 Cr., calculated based on its latest share price.
Q3. What are the P/E and P/B ratios of Chemopulp Tissues?
Ans: The PE ratio of Chemopulp Tissues is 0 and the P/B ratio of Chemopulp Tissues is 0, showing how the stock is valued against its earnings and book value.
Q4. What is the 52-week high and low of Chemopulp Tissues share?
Ans: The 52-week high share price of Chemopulp Tissues is Rs 0, and the 52-week low share price of Chemopulp Tissues is Rs 0.
Q5. Does Chemopulp Tissues pay dividends?
Ans: Currently, Chemopulp Tissues does not pay dividends. Dividend yield of Chemopulp Tissues is around 0%.
Q6. What are the face value and book value of Chemopulp Tissues shares?
Ans: The face value of Chemopulp Tissues shares is Rs 10, while the book value per share of Chemopulp Tissues is around Rs 15.0363. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.
Q7. What is the debt of Chemopulp Tissues?
Ans: Chemopulp Tissues has a total debt of Rs 0.2469784 Cr., which affects investor sentiment and financial stability.
Q8. What are the ROE and ROCE of Chemopulp Tissues?
Ans: The ROE of Chemopulp Tissues is -6.54616421862709% and ROCE of Chemopulp Tissues is -5.18888883636137%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.
Q9. Is Chemopulp Tissues a good buy for the long term?
Ans: The Chemopulp Tissues long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.
Q10. Is Chemopulp Tissues undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Chemopulp Tissues appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.
Q11. How to check Chemopulp Tissues’s financials?
Ans: You can review Chemopulp Tissues’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.